Presumed Natural History of Combined Hamartoma of the Retina and Retinal Pigment Epithelium.


Journal

Ophthalmology. Retina
ISSN: 2468-6530
Titre abrégé: Ophthalmol Retina
Pays: United States
ID NLM: 101695048

Informations de publication

Date de publication:
11 2021
Historique:
received: 23 09 2020
revised: 17 01 2021
accepted: 21 01 2021
pubmed: 1 2 2021
medline: 29 1 2022
entrez: 31 1 2021
Statut: ppublish

Résumé

To correlate structural changes of combined hamartoma of the retina and retinal pigment epithelium (CHRRPE) with patient age. Retrospective study. Fifty eyes of 49 patients (age range, 1-74 years) with CHRRPE studied at 9 tertiary vitreoretinal institutions. We analyzed the clinical findings with respect to lesion topography and pigmentation as well as investigated the OCT findings regarding the thickness, vitreoretinal interface, outer plexiform layer distortion, ellipsoid zone disruption, and retinal pigment epithelium-Bruch's membrane complex involvement of CHRRPE. Clinical and imaging findings of CHRRPE at different ages. Analysis of 50 CHRRPE patients revealed that younger patients were more likely to demonstrate partial thickness involvement of the retina (P = 0.009) with predominantly inner retinal layer involvement (P = 0.04). The inverse was true for older patients with CHRRPE. In addition, older patients more commonly showed pigmentary changes. Eyes with CHRRPE were more likely to show an increase in central macular thickness independently of tumor location. Based on these findings, we believe that CHRRPE typically begins in the inner retina and continues toward the outer retina over time, with increase in central macular thickness, despite the location of the tumor.

Identifiants

pubmed: 33516918
pii: S2468-6530(21)00033-6
doi: 10.1016/j.oret.2021.01.011
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1156-1163

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Gerardo Ledesma-Gil (G)

Vitreous Retina Macula Consultants of New York, New York, New York; Retina Department, Institute of Ophthalmology, Fundación Conde de Valenciana, Mexico City, Mexico.

Juliet Essilfie (J)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, Manhattan Eye, Ear and Throat Hospital, New York, New York; Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York.

Rajan Gupta (R)

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India.

Adrian T Fung (AT)

Westmead Hospital, Sydney, Australia; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia; Save Sight Institute, University of Sydney, Sydney, Australia.

Marco Lupidi (M)

Department of Biomedical and Surgical Sciences, Section of Ophthalmology, University of Perugia, S. Maria della Misericordia Hospital, Perugia, Italy.

Rajeev R Pappuru (RR)

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India.

Sameera Nayak (S)

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India.

Niroj Kumar Sahoo (NK)

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India.

Swathi Kaliki (S)

The Operation Eyesight Universal Institute for Eye Cancer, L. V. Prasad Eye Institute, Hyderabad, India.

Lawrence A Yannuzzi (LA)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York; LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, New York, New York.

Kate Reid (K)

Department of Ophthalmology, Canberra Hospital, Canberra, Australia; School of Clinical Medicine, Australian National University, Canberra, Australia.

Lianne Lim (L)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Riccardo Sacconi (R)

Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.

Vivek Dave (V)

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India.

Sumit R Singh (SR)

Jacobs Retina Center at Shiley Eye Institute, University of California at San Diego, La Jolla, California.

Apoorva Ayachit (A)

Department of Vitreoretina, M. M. Joshi Eye Institute, Hubballi, Karnataka, India.

Pierre-Henry Gabrielle (PH)

Ophthalmology Department, Dijon University Hospital, Dijon, France; Center for Taste and Feeding Behaviour, INRA, Dijon, France.

Sophie Cai (S)

Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Luiz H Lima (LH)

Federal University of São Paulo, São Paulo, Brazil.

Giuseppe Querques (G)

Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.

J Fernando Arevalo (JF)

Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

K Bailey Freund (KB)

Vitreous Retina Macula Consultants of New York, New York, New York; Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York; LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat Hospital, New York, New York.

Carol L Shields (CL)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Jay Chhablani (J)

UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: jay.chhablani@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH